Penn Medicine Abramson Cancer Center


 

Phase I Study of Autologous T-Cells Bearing Fully-Humanized CARs Targeting Mesothelin in Mesothelin-Expressing Cancers

16 views
September 14, 2021
Comments 0
Login to view comments. Click here to Login